Rite-Aid filed for bankruptcy in July and closed nearly 74 stores this year. Walgreens CEO Tim Wentworth also announced ...
Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...
Taking into account the latest results, the current consensus from CVS Health's 23 analysts is for revenues of US$385.9b in ...
J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...
Mizuho lowered the firm’s price target on CVS Health (CVS) to $66 from $73 and keeps an Outperform rating on the shares. The firm cut estimates following last week’s preannouncement.